A Safe Choice
- The La Crosse Method Protocol has helped more than 195,000 allergy sufferers in nearly 50 years without a single life-threatening reaction reported. No other published sublingual immunotherapy method can make this claim. The La Crosse Method’s safety record is impressive in view of how many allergies and allergic conditions it helps.
- The La Crosse Method is the only U.S. published sublingual immunotherapy protocol that has been safely used for decades with young children and even infants. The younger your child’s allergies are treated, the more likely there is a chance to impact the developing immune system and stop the progression of allergies. Early treatment is more likely to prevent allergic diseases such as:
- The La Crosse Method is the only published allergy protocol with decades of U.S. clinical use that is safe for people with severe allergies or uncontrolled asthma, women who are pregnant, and patients taking beta blockers. Even the most allergic people can be safely and successfully treated using the La Crosse Method. Am I a candidate for sublingual immunotherapy?